In this property, MI-63 is similar to Nutlin-3a, which has previously been shown to induce synergistic activity with bortezomib [31], [32] against in vitro myeloma models, largely in association with a p53-mediated cell death program. The gene discussed is TP53; the disease is plasma cell myeloma.